research FEATURES OF THE DEVELOPMENT OF ACUTE DIFFUSE TELOGEN EFFLUVIUM IN PATIENTS WITH POST-COVID SYNDROME
Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.
Search
for
Sort by
Research
750-780 / 1000+ results research INFLUÊNCIA DO VÍRUS DA COVID-19 NO AUMENTO DO NÚMERO DE CASOS DE EFLÚVIO TELÓGENO
COVID-19 may increase hair loss due to stress and inflammation.
research Clinical Spectrum and Outcomes of Post-COVID Syndrome Among Adults in Rural Kerala: A Cohort Study
Post-COVID syndrome symptoms are common and overlap with general health issues.
research COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings
Many COVID-19 patients still have symptoms like fatigue and loss of taste or smell a month after diagnosis.
research Prognostic biomarkers of symptom persistence in COVID-19 in an outpatient cohort from Niterói-RJ
Complete COVID-19 vaccination reduces the risk of long COVID.
research Characterization of post-COVID syndrome by self-perceived symptom severity stratified by infection wave: beyond COVID, a prospective, multicenter cohort study in Germany
Most people with post-COVID syndrome experience symptoms like fatigue, but Omicron variants cause fewer persistent symptoms.
research ШКІРНІ ПРОЯВИ ПРИ COVID-19 ТА НА ЕТАПІ ПОСТКОВІДНОГО СИНДРОМУ
COVID-19 can cause skin issues during and after infection.
research Effect of COVID-19 outbreak on hair transplant field of India
The COVID-19 pandemic caused most hair transplant surgeons in India to stop working, and many planned to change their safety measures afterwards.
research A Retrospective Analysis from Turkey: The Effect of the COVID-19 Outbreak Quarantine on Dermatology Outpatient Clinics
The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.
research COVID-19 infection is a major cause of acute telogen effluvium
COVID-19 infection can significantly cause temporary hair loss.
research Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization
COVID-19 can cause hair loss starting as early as 18 days after infection.
research Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.
research COVID-19 Pandemic is Not Over for Survivors with Long COVID Syndrome: Evidence of a One-Year Retrospective Follow-up Study from Iran
Long COVID affects many survivors, showing the need for ongoing care.
research Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin
COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.
research Case Report: Alopecia areata in an adolescent after COVID-19 infection
COVID-19 may trigger hair loss conditions like alopecia areata.
research Telogen effluvium in covid-19 patients: a cross-sectional survey
COVID-19 often causes hair loss, especially in women.
research Long COVID and Post-Covid Conditions (PCC) in 2025
Long COVID can cause lasting health issues like fatigue and brain fog, especially in those with severe initial infections or no vaccination.
research The association of hair loss and coronavirus infection COVID-19 – facts and hypotheses
COVID-19 may cause different types of hair loss, and the virus's effects on hair could help understand its impact on other body parts.
research Hair loss following COVID-19 infection - the state of current knowledge and treatment approaches.
COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.
research Eflúvio Telógeno após a infecção por COVID 19: uma revisão narrativa sobre o mecanismo fisiológico / Telogen Effluvium after SARS-CoV-2 infection: a narrative review of physiological mechanism
COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.
research CAPILLARY DISEASES IN PATIENTS WHO HAD COVID-19
Covid-19 may cause hair loss conditions like alopecia areata and telogen effluvium.
research Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
The Pfizer COVID-19 vaccine may rarely trigger nail psoriasis.
research Italian Survey for the Evaluation of the Effects of Coronavirus Disease 2019 (COVID-19) Pandemic on Alopecia Areata Recurrence
COVID-19 increased alopecia areata relapses due to inflammation and stress.
research Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
COVID-19 vaccines can cause mild to moderate skin reactions, mostly after the first dose.
research Retrospective Evaluation of the Impact of the COVID-19 Pandemic on the Incidence of Alopecia Areata in a Single Dermatological Department
COVID-19 pandemic increased alopecia areata cases and hospitalizations.
research Association of alopecia areata with COVID-19 vaccination: A vaccine adverse events reporting system analysis
COVID-19 vaccination may be linked to alopecia areata, especially in young adults.
research New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination
COVID-19 vaccination may trigger lupus in some people.
research COVID-19: Evaluation and Care of Patients With Persistent Symptoms Following Acute SARS-CoV-2 Infection
Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.
research Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia
Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.
research Therapy experience in alopecia after COVID-19
The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.